These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection. Afdhal N, Zeuzem S, Kwo P, Chojkier M, Gitlin N, Puoti M, Romero-Gomez M, Zarski JP, Agarwal K, Buggisch P, Foster GR, Bräu N, Buti M, Jacobson IM, Subramanian GM, Ding X, Mo H, Yang JC, Pang PS, Symonds WT, McHutchison JG, Muir AJ, Mangia A, Marcellin P, ION-1 Investigators. N Engl J Med; 2014 May 15; 370(20):1889-98. PubMed ID: 24725239 [Abstract] [Full Text] [Related]
15. Generic ledipasvir-sofosbuvir for patients with chronic hepatitis C: A real-life observational study. Zeng QL, Xu GH, Zhang JY, Li W, Zhang DW, Li ZQ, Liang HX, Li CX, Yu ZJ. J Hepatol; 2017 Jun 15; 66(6):1123-1129. PubMed ID: 28189754 [Abstract] [Full Text] [Related]
19. Efficacy of ledipasvir and sofosbuvir, with or without ribavirin, for 12 weeks in patients with HCV genotype 3 or 6 infection. Gane EJ, Hyland RH, An D, Svarovskaia E, Pang PS, Brainard D, Stedman CA. Gastroenterology; 2015 Nov 15; 149(6):1454-1461.e1. PubMed ID: 26261007 [Abstract] [Full Text] [Related]